wherea
aerosol
contact
accept
mode
transmit
mani
organ
includ
legionella
pneumophila
smallpox
sever
acut
respiratori
syndrom
sar
coronavirus
rhinoviru
fiegel
et
al
tuberculosi
well
riley
et
al
mcclement
christianson
role
bioaerosol
transmiss
mechan
influenza
less
clearli
understood
tellier
tellier
b
lemieux
brankston
brankston
et
al
tang
lee
although
public
document
transmiss
influenza
inhal
rout
tellier
studi
date
util
mous
model
investig
suscept
pathogen
measur
aerosol
exposur
lack
aerobiolog
studi
result
sever
factor
includ
need
special
equip
gener
monitor
bioaerosol
technic
difficulti
involv
inconsist
among
report
techniqu
lore
et
al
consider
cost
conduct
research
sherwood
et
al
therefor
commonli
describ
method
infect
mice
influenza
viru
instal
fluid
nasal
passag
lu
et
al
govorkova
et
al
et
al
chen
et
al
year
laboratori
mice
serv
model
suscept
pathogenesi
influenza
diseas
andrew
et
al
low
cost
small
size
rel
suscept
viru
eas
handl
make
mice
favour
platform
studi
influenza
viru
infect
mous
current
consid
primari
model
evalu
influenza
antivir
agent
predict
indic
efficaci
treatment
human
sidwel
smee
use
mous
model
especi
import
studi
infecti
pathway
new
pandem
pdm
subtyp
influenza
inde
latest
emerg
influenza
reignit
interest
use
mous
model
beigel
bray
although
mathemat
model
use
decad
findeisen
yeh
et
al
intern
commiss
radiolog
protect
icrp
asgharian
anjilvel
heyder
calcul
particl
deposit
within
respiratori
tract
calcul
particl
placement
abl
ration
predict
result
clinic
effect
anim
model
allow
closer
approxim
human
respons
schulman
lowen
et
al
gustin
et
al
therefor
import
continu
develop
model
fouchier
et
al
kawaoka
experiment
inhal
exposur
system
establish
tool
subject
sever
review
drew
laskin
macfarland
cheng
moss
jaeger
et
al
wong
purpos
studi
identifi
evalu
mous
model
complement
bioaerosol
deliveri
apparatu
term
cat
control
aerosol
test
system
test
clinic
effect
media
use
respiratori
protect
equip
rpe
valid
includ
complementari
data
measur
postmortem
render
mice
avail
serv
detector
evalu
clinic
signific
articl
rpe
directli
measur
chang
infect
protect
articl
caus
exposur
influenza
viru
often
lead
diseas
present
acut
temporarili
incapacit
infect
upper
respiratori
tract
fatal
influenza
ill
often
associ
occurr
annual
epidem
temper
climat
zone
within
last
year
influenza
pandem
occur
four
time
oxford
pandem
infrequ
often
sever
event
emerg
novel
unpredict
strain
influenza
viru
caus
recombin
genet
materi
two
circul
viru
subtyp
antigen
shift
often
lead
new
viru
subtyp
abil
jump
one
speci
anoth
potenti
naiv
speci
eg
avian
influenza
caus
larg
proport
death
number
anim
model
studi
evalu
new
vaccin
approach
prevent
diseas
gubareva
et
al
ng
et
al
green
kass
conduct
studi
clearanc
inhal
microbi
aerosol
murin
respiratori
tract
schulman
kilbourn
studi
transmiss
influenza
viru
factor
complic
viral
research
anim
model
viru
may
present
host
without
caus
diseas
may
due
restrict
absenc
appropri
receptor
certain
cell
type
eg
tissu
tropism
lack
intracellular
process
requir
gener
infecti
progeni
virus
induc
cytolyt
effect
differ
viral
receptor
document
respiratori
epitheli
cell
base
locat
either
pharynx
peripher
lung
van
riel
et
al
addit
either
organ
host
cell
may
mount
immun
respons
gener
intracellular
molecul
disrupt
viral
effect
therefor
differ
may
appear
either
cellular
tissu
level
among
suscept
host
depend
upon
method
infect
especi
regard
aerosol
exposur
phalen
et
al
studi
examin
paramet
relat
effici
near
threshold
infect
versu
overwhelm
infect
mice
exposur
aerosol
influenza
viru
cat
apparatu
design
construct
valid
stone
stone
et
al
deliv
precis
measur
aerosol
concentr
either
directli
passag
filter
medium
inhal
exposur
system
noi
ch
technolog
westwood
nj
usa
jaeger
et
al
individu
mice
fig
design
consist
aerosol
gener
diffus
drier
charg
neutral
filter
holder
sampl
point
noi
unit
stone
stone
et
al
cat
gener
biolog
aerosol
rang
constant
concentr
condit
treatment
appli
deliv
particl
nose
mous
constrain
polycarbon
tube
ch
technolog
pure
respiratori
exposur
main
system
compon
connect
use
stainless
steel
tube
minimum
number
gradual
bend
oper
collison
nebul
bgi
inc
waltham
usa
regul
psi
use
atom
viral
suspens
aerosol
acquir
surfac
charg
atom
pass
diffus
drier
charg
neutral
tsi
inc
shoreview
mn
usa
restor
normal
boltzmann
equilibrium
charg
distribut
passag
filter
holder
filter
medium
mount
aerosol
enter
noi
exit
test
system
exhaust
total
flow
rate
system
regul
nebul
deliv
l
measur
exit
mass
flow
metr
tsi
model
entir
system
design
fit
insid
biolog
safeti
cabinet
baker
compani
sanford
usa
addit
protect
gener
aerosol
uniqu
featur
system
option
filter
holder
triosyn
corp
williston
vt
usa
capabl
hold
filter
media
sampl
mm
diamet
smaller
disc
filter
media
accommod
use
reduc
stone
et
al
stone
demonstr
uniform
distribut
aerosol
sever
port
cat
follow
transport
instal
cat
anim
biosafeti
level
facil
univers
nebraska
medic
center
exposur
system
retest
verifi
consist
particl
count
among
port
use
tap
water
gener
test
aerosol
particl
exposur
port
sampl
particl
deliv
collison
nebul
measur
triplic
use
scan
mobil
particl
sizer
smp
system
tsi
inc
minneapoli
mn
usa
aerosol
particl
size
concentr
determin
use
l
sheath
air
l
sampl
air
data
output
smp
collect
aerosol
instrument
softwar
ver
tsi
inc
minneapoli
mn
usa
influenza
viru
obtain
american
type
cultur
collect
rockvil
md
usa
frozen
stock
atcc
viru
propag
use
cdc
unit
protocol
szretter
et
al
titr
perform
calcul
use
method
armitag
allen
finney
assess
psd
aerosol
contain
influenza
viru
sampl
taken
triplic
sampl
port
locat
downstream
cat
dilut
filter
air
rout
smp
result
indic
polydispers
aerosol
size
rang
nm
three
strain
femal
mice
balbc
purchas
charl
river
laboratori
portag
facil
mi
usa
mice
week
old
rang
weight
g
mice
randomli
divid
group
assign
specif
exposur
time
point
five
given
exposur
group
hous
per
cage
anim
provid
rodent
chow
harlan
teklad
usa
water
ad
libitum
maintain
lightdark
cycl
anim
work
carri
facil
follow
institut
regulatori
procedur
minim
artefact
caus
stress
respiratori
exposur
session
mice
precondit
daili
week
preced
exposur
session
nrc
insert
mous
restraint
devic
ch
technolog
period
exceed
maximum
exposur
time
experi
select
suitabl
mous
strain
infect
influenza
strain
use
studi
two
inbr
balbc
one
strain
g
femal
mice
test
suscept
infect
viru
individu
base
weight
determin
prior
exposur
mice
weigh
daili
uniform
schedul
time
throughout
studi
averag
weight
surviv
expos
mice
day
compar
averag
control
mice
mice
euthan
day
postinocul
inoculum
consist
viru
concentr
median
tissu
cultur
infecti
dose
place
intranas
mous
dose
divid
equal
place
pipett
nari
anesthet
ketaminexylazin
mous
follow
procedur
dilut
viru
stock
salin
pb
medium
use
inocul
second
set
mice
three
strain
five
mice
per
strain
per
dilut
use
determin
suscept
viru
three
mice
per
strain
use
control
control
mous
intranas
inocul
total
pb
medium
previous
describ
jerrel
et
al
preliminari
studi
conduct
establish
baselin
dose
viru
capabl
caus
infect
follow
aerosol
work
stock
influenza
viru
dilut
water
sigma
st
loui
mo
usa
deliv
collison
nebul
four
set
three
mice
emplac
polycarbon
restraint
instal
noi
filter
holder
empti
expos
aerosol
viru
exposur
time
min
aliquot
influenza
work
stock
titr
subsequ
dilut
vv
water
prepar
concentr
aerosol
three
success
mous
exposur
seri
describ
collison
nebul
charg
allow
run
min
stabil
system
bypass
valv
directli
upstream
cat
direct
aerosol
two
hepa
filter
connect
seri
exposur
initi
nonanesthet
mice
care
immobil
polycarbon
tube
tip
nose
project
open
front
holder
tube
insert
secur
port
cat
anim
emplac
test
aerosol
direct
system
vent
insid
caviti
cat
direct
airstream
contain
filter
aerosol
nare
mous
sourc
breath
air
excess
aerosol
flow
exhal
air
continu
swept
away
preclud
inhal
previous
exhal
air
spread
deliv
dose
proport
concentr
c
time
around
dilut
achiev
vari
time
exposur
bioaerosol
dose
receiv
calcul
follow
dp
present
dose
viral
vsf
ratio
viabl
airborn
count
viabl
count
collison
reservoir
r
respir
rate
per
minut
v
tidal
volum
mla
ml
air
respect
mous
r
v
report
fairchild
respirationsmin
mla
respect
thu
mous
expos
min
dilut
suspens
contain
viru
inhal
dose
mice
expos
group
preselect
time
tabl
end
exposur
period
polycarbon
tube
hold
mice
remov
next
group
insert
mice
seri
experi
expos
time
point
allow
mice
insert
overlap
group
unus
port
seal
supplier
standard
plug
exposur
carri
within
biolog
safeti
cabinet
control
mice
exposur
group
place
polycarbon
tube
test
equal
maximum
exposur
time
expos
aerosol
gener
water
sigma
contain
viru
exposur
group
two
set
control
use
one
mous
group
expos
earlier
second
group
expos
uninfect
allanto
fluid
process
manner
egg
mice
observ
weigh
day
postexposur
sever
distress
mice
euthan
day
weigh
follow
final
weigh
surviv
mice
euthan
administr
overdos
ketaminexylazin
intraperiton
inject
necropsi
conduct
select
portion
lung
select
molecular
histolog
viru
cultur
assess
lung
tissu
asept
place
ml
cold
bd
univers
viru
transport
medium
becton
dickinson
co
franklin
lake
nj
usa
homogen
hand
use
close
ultra
tissu
grinder
system
fisher
scientif
pittsburgh
pa
usa
store
start
viral
titr
quantifi
cell
cultur
assay
perform
use
canin
kidney
mdck
cell
calcul
use
method
unit
cell
cultur
plate
contain
mdck
cell
grown
maintain
use
standard
cell
cultur
techniqu
presenc
viabl
viru
homogen
murin
lung
tissu
qualit
assess
cell
cultur
endpoint
assay
perform
use
mdck
cell
cell
cultur
plate
contain
mdck
cell
grown
maintain
use
standard
cell
cultur
techniqu
aliquot
ml
lung
homogen
plate
serial
dilut
eagl
minim
essenti
medium
emem
quadrupl
confluent
cell
monolay
sampl
remain
contact
monolay
incub
emem
trypsin
ad
bovin
serum
albumin
plate
incub
day
prior
visual
microscop
cytopath
effect
cpe
antibodi
evalu
test
plate
read
use
system
show
disrupt
monolay
show
monolay
remain
confluent
direct
fluoresc
antibodi
assay
dfa
use
qualit
determin
influenza
infect
mdck
cell
line
use
ultra
dfa
respiratori
viru
screen
id
kit
diagnost
hybrid
inc
athen
oh
usa
per
manufactur
instruct
ribonucl
acid
rna
extract
sampl
use
spin
kit
follow
manufactur
protocol
qiagen
valencia
ca
usa
rna
amplif
perform
use
invitrogen
superscript
iii
platinum
quantit
polymeras
chain
reaction
kit
invitrogen
grand
island
ny
usa
assay
run
roch
pcr
system
roch
diagnost
indianapoli
assay
condit
reaction
volum
use
protocol
previous
describ
cdc
cycl
threshold
ct
valu
replic
run
averag
time
point
round
two
decim
place
recommend
ct
valu
use
criterion
infect
follow
fixat
routin
process
tissu
section
stain
hematoxylin
eosin
review
standard
light
microscopi
compar
normal
tissu
lung
show
lobular
pneumonia
interbronchi
inflamm
infect
lung
also
show
focal
chronic
inflammatori
cell
infiltr
neutrophil
interstiti
thicken
figur
show
infiltr
infect
tissu
compar
uninfect
tissu
instal
cabinet
reverif
cat
perform
conduct
water
particl
count
port
averag
seen
uniform
within
data
shown
subsequ
deliveri
mg
sodium
chlorid
water
show
number
mean
diamet
n
nm
mass
mean
diamet
nm
rang
particl
diamet
nm
figur
plot
coeffici
variat
cov
function
particl
size
port
nacl
aerosol
measur
group
five
mice
inocul
intranas
one
two
dose
viru
weigh
daili
week
per
cent
chang
averag
weight
expos
control
group
indic
tabl
influenza
viru
produc
obviou
infect
three
strain
mice
use
differ
gross
infect
indic
weight
loss
tabl
mice
select
studi
two
mice
use
unexpos
control
mice
surviv
day
euthan
necropsi
lung
tissu
examin
three
differ
assay
four
exposur
time
point
mous
lung
tissu
gave
posit
result
assay
posit
valu
defin
ct
dfa
cpe
assay
lung
tissu
also
posit
tabl
direct
correl
dose
receiv
conveni
reckon
ct
valu
product
concentr
exposur
time
lower
pcr
ct
valu
result
prolong
exposur
mean
ct
valu
control
mice
defin
neg
respons
valu
ct
consid
indetermin
weight
loss
show
proportion
dose
deliv
result
demonstr
influenza
viru
remain
viabl
capabl
caus
infect
mice
aerosol
test
condit
exposur
dilut
aerosol
viru
result
massiv
graduat
infect
test
mice
greater
dilut
work
stock
deliv
effort
identifi
threshold
infect
dose
dilut
increas
tenfold
result
deliveri
dispers
nebul
overlap
ct
product
two
smaller
dose
dilut
initi
aerosol
exposur
sequenc
repeat
three
mice
per
time
point
assay
variat
ct
valu
observ
exposur
group
one
mous
clearli
posit
reflect
ct
valu
two
mice
fall
within
indetermin
rang
tabl
mice
time
point
posit
ct
minim
variat
ct
valu
control
mice
neg
ct
valu
assay
perform
mice
group
time
point
one
mous
lung
homogen
group
indetermin
ct
neg
assay
lung
homogen
test
posit
method
although
weight
loss
mice
appear
reach
baselin
dose
deliv
min
dilut
ct
result
aerosol
challeng
dilut
show
mice
expos
min
receiv
infecti
dose
weight
loss
indic
dose
ct
measur
provid
better
sensit
detect
endpoint
effort
better
defin
threshold
viral
infect
occur
stock
suspens
dilut
exposur
time
reduc
number
mice
per
time
group
increas
five
two
addit
time
point
ad
increas
rang
dose
aerosol
exposur
result
test
shown
tabl
exposur
time
mice
posit
influenza
viru
determin
ct
valu
four
group
singl
mous
display
posit
ct
valu
trend
may
suggest
pattern
indetermin
valu
quantit
ct
valu
show
equal
unconvinc
opposit
trend
lung
homogen
test
viru
cell
cultur
assay
dfa
homogen
whose
ct
valu
dfa
posit
accept
influenza
may
contract
varieti
method
includ
larg
droplet
contact
transmiss
rout
infect
examin
studi
inhal
droplet
nuclei
nasal
passageway
result
expect
differ
mucos
surfac
dose
viral
aerosol
studi
sought
determin
exist
scale
measur
threshold
aerosol
infect
dose
anim
model
set
paramet
mous
restraint
experi
limit
exposur
although
studi
demonstr
infect
aerosol
resid
time
dispers
fine
particl
short
hundr
millisecond
nozzl
nose
virus
known
spontan
lose
viabil
import
bioaerosol
environment
compon
remain
uncertain
howev
experi
accur
simul
direct
exposur
droplet
nuclei
gener
cough
accordingli
conclud
mechan
immedi
transmiss
viru
rang
state
result
influenza
viru
span
asymptomat
infect
mild
symptom
pneumonia
often
fatal
factor
strain
influenza
viru
caus
ill
immun
statu
host
andor
age
affect
individu
play
import
role
recoveri
progress
diseas
evid
outbreak
influenza
influenza
viru
pandem
pdm
strain
disproportion
high
percentag
morbid
occur
children
young
adult
well
individu
underli
condit
obes
diabet
jhung
et
al
influenza
viru
select
studi
chosen
base
report
infect
mice
smee
et
al
although
mous
adapt
known
hardi
cultur
system
start
point
develop
mous
model
aerosol
influenza
result
show
signific
variabl
morbid
mortal
among
mice
expos
aerosol
influenza
viru
appear
owe
individu
suscept
mice
variabl
uniform
aerosol
deliv
found
signific
port
analys
addit
signific
differ
note
mice
expos
time
rang
min
minim
morbid
low
quantiti
viru
spray
extend
period
time
prefer
explan
mice
abl
process
clear
viru
other
caus
clinic
infect
diseas
addit
hardi
immun
respons
influenza
vari
among
mice
result
differ
level
suscept
exampl
tabl
lowest
exposur
time
one
three
mice
posit
infect
wherea
lowest
dose
experi
tabl
one
mous
posit
follow
min
exposur
mani
virus
influenza
produc
signific
number
defect
particl
incap
caus
infect
huang
pathak
nagi
demonstr
wide
variat
rang
hundr
thousand
report
gene
copi
total
virion
infecti
virion
fraction
ratio
yang
et
al
sidorenko
reichl
develop
mathemat
model
describ
complet
life
cycl
influenza
anim
cell
model
base
multipl
infect
moi
virion
per
cell
suggest
influenza
replic
within
h
postinfect
produc
progeni
virion
cell
death
occur
perrott
et
al
report
detect
level
influenza
use
use
nest
recogn
direct
correl
may
alway
exist
method
detect
viabl
organ
one
base
viral
genom
system
show
excel
correl
classic
virolog
method
morpholog
base
histolog
examin
clinic
featur
molecular
quantif
influenza
infect
mice
monitor
sever
differ
paramet
includ
mean
time
death
lung
weight
chang
bodi
weight
sidwel
smee
howev
indic
difficult
interpret
infect
challeng
dose
viru
clinic
manifest
ill
morbid
mortal
therefor
util
comparison
minim
variabl
viru
replic
lung
tissu
consid
inform
endpoint
efficaci
studi
even
modest
chang
viru
load
larg
impact
surviv
haga
horimoto
assay
postsacrific
tissu
sampl
mice
uniformli
posit
dilut
seri
contrast
data
shown
fig
dilut
seri
exposur
dose
group
contain
subject
unequivoc
posit
infect
ct
cpe
anova
find
statist
differ
chang
mous
weight
pcr
data
howev
precis
threshold
valu
statist
signific
differ
expect
number
mice
n
exposur
group
increas
likewis
two
set
subject
share
ct
product
min
min
min
min
appear
show
increas
sensit
increas
aerosol
concentr
could
taken
impli
acut
exposur
lead
greater
infect
dose
experienc
gradual
although
interpret
intuit
reason
volum
data
support
limit
justifi
conclus
owe
logist
constraint
facil
psd
measur
exposur
howev
stone
et
al
stone
measur
bioaerosol
particl
rang
nm
slightli
smaller
viru
coli
phage
apparatu
absorb
dose
like
slightli
smaller
present
dose
deposit
inspir
particl
size
rang
incomplet
size
depend
stuart
clay
clark
heyder
plot
weight
loss
vs
calcul
inhal
dose
fig
fit
straight
line
intersect
mean
weight
chang
control
group
approxim
third
seri
exposur
perform
dilut
intend
improv
definit
threshold
dose
weight
loss
howev
result
equivoc
like
deliveri
gradual
enough
mice
develop
immun
respons
abl
manag
challeng
andor
n
five
small
averag
presum
idiosyncrasi
among
subject
result
show
sensit
excess
genom
present
comparison
number
infecti
virion
determin
dfa
assay
gold
standard
schrauwen
et
al
determin
moi
quantif
viru
mice
expos
influenza
aerosol
previous
report
addit
confirmatori
studi
need
chose
seven
day
termin
point
studi
base
symptomatolog
human
viru
product
peak
approxim
h
postinfect
viru
particl
shed
day
taubenberg
moren
result
show
deliv
aerosol
least
determin
ct
valu
significantli
determin
obviou
clinic
respons
howev
sampl
size
must
expand
futur
achiev
greater
resolut
statist
signific
addit
futur
studi
util
influenza
viru
pdm
strain
determin
variat
two
strain
data
method
present
contribut
fundament
basi
refin
studi
aerosol
deliveri
particl
anim
model
studi
varieti
clinic
subject
infecti
dose
vaccin
deliveri
work
need
precis
defin
median
infect
dose
current
influenza
strain
mous
better
understand
effect
bioaerosol
age
dose
rate
infect
work
present
herein
valid
aerosol
one
organ
deliveri
pure
respiratori
pathway
one
murin
host
techniqu
assay
infect
challeng
bioaerosol
work
serv
start
point
continu
work
use
microbi
organ
anim
host
intend
applic
aerosol
influenza
anim
model
describ
assess
clinic
effect
respiratori
protect
devic
incorpor
antimicrobi
treatment
variou
approach
propos
increas
effect
respiratori
filter
media
includ
addit
bioactiv
media
although
materi
silver
nanoparticl
lala
et
al
copper
oxid
borkow
et
al
iodin
compound
heimbuch
wander
other
cecchini
et
al
shown
biocid
potenti
iodin
vector
propos
lee
et
al
oper
noncontact
mechan
addit
studi
focu
evalu
new
technolog
replac
filter
holder
larger
enclosur
abl
collect
aerosol
behind
filter
facepiec
respir
ffr
worn
articul
headform
quantifi
effect
protect
seal
leakag
optim
particl
remov
effici
ffr
rpe
maxim
net
protect
